Publication dates

All regions

Breast Cancer Industry, January 2015 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, melanoma, therapeutics, prostate cancer, drug, mammography, medical center, colorectal cancer, oncology, ultrasound, magnetic resonance imaging, hospital, lymphoma, cancer drug.


 
1-10 of about 300 reports for Breast Cancer

Medical Industry Week 19 JANUARY 2015

Medical Industry Week 19 JANUARY 2015

  • $ 1 114
  • Industry report
  • January 2015
  • by Espicom Business Intelligence

... Appetite growing for 3d printingindustry trend analysis - nodea's breast cancer imaging technique offers incentive to ditch biopsiesindustry brief - silver bullet secures us patent for controlled ...

Breast Cancer Drug Pathway Analyzer 2015

Breast Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

... Seeker, a leader in pipeline analytics, has constructed this high-level drug-pathway analyzer which lets you interact with the breast cancer pipeline in a whole different than way than you ever done before. Its ...

Bavarian Nordic A/S (Symbol:BAVA) SWOT Analysis, Strategy, Revenues and Profits

Bavarian Nordic A/S (Symbol:BAVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Such as smallpox, prostate cancer, anthrax, breast cancer, marburg and ebola infections, among others. The company also develops viral vaccines for research, clinical and commercial applications. It operates ...

Bio-Path Holdings, Inc. (Symbol:BPTH) SWOT Analysis, Strategy, Revenues and Profits

Bio-Path Holdings, Inc. (Symbol:BPTH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Its products are used in the treatment of lymphoma, chronic myelogenous leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, breast cancer, colon cancer, prostate ...

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Blood transcriptome analysis and data mining. The company's diagnostic areas include colon cancer, lung cancer, prostate cancer and breast cancer. Its products are available in canada, malaysia, china ...

IsoRay, Inc. (Symbol:ISR) SWOT Analysis, Strategy, Revenues and Profits

IsoRay, Inc. (Symbol:ISR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Gynecological, and prostate. It has manufacturing facility in applied process engineering laboratory. Isoray's cesium-131 used in other solid fast growing tumor applications, such as breast cancer, liver cancer ...

ViroMed Co., Ltd. (Symbol:084990) SWOT Analysis, Strategy, Revenues and Profits

ViroMed Co., Ltd. (Symbol:084990) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Are used to treat critical limb ischemia, diabetic peripheral neuropathy, acute myocardinal infarction, angina pectoris, breast cancer, allergic disease, and atopic dermatitis and dry skin. The company ...

Merrion Pharmaceuticals Plc (Symbol:3MP) SWOT Analysis, Strategy, Revenues and Profits

Merrion Pharmaceuticals Plc (Symbol:3MP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Almero, acyline and mer-102. Its products find application in the treatment of diseases such as bone metastases, breast cancer, osteoporosis, prostate cancer and deep vein thrombosis. The company has ...

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Different types of multidrug resistant cancer cell lines including breast cancer, uterine carcinoma, pancreatic cancer and small-cell lung cancer. Sunshine biopharma also offers difluoro-etoposide, which ...

TapImmune Inc. (Symbol:TPIV) SWOT Analysis, Strategy, Revenues and Profits

TapImmune Inc. (Symbol:TPIV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Neu breast cancer vaccine approach has the potential to treat 85% of her2/neu breast cancer patients. Its polystart vaccine is used to treat oncology and infectious diseases. The company's product ...

About 4 200 reports for Breast Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2013
    40 pages
  • Breast Cancer  

    Cancer  

  • United States  

    North America  

View report >

4 Companies for Breast Cancer

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Eli Lilly and Co.

United States

AstraZeneca PLC

United Kingdom

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.